Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Challenges in genital herpes simplex virus management Corey LJ Infect Dis 2002[Oct]; 186 Suppl 1 (ä): S29-33Development of serologic assays to detect antibodies to herpes simplex virus (HSV) glycoproteins (g)G1 and (g)G2 has allowed accurate definition of the seroprevalence of HSV-2 worldwide. Studies from all continents indicate epidemic proportions of HSV-2 infection. In the United States, 1 in 5 sexually active adults is infected. In Africa and the Caribbean, HSV prevalence is higher. Since the development of the acyclic nucleoside derivatives acyclovir, famciclovir, and valacyclovir, treatment of mucocutaneous HSV is a practice of everyday medical care. Yet, despite effective drugs, there is widespread discontent by clients and providers about care of patients with genital herpes. Much of this relates to transmission complexities and the varied natural history of the infection. However, over time, most patients adjust to their disease and the medical and psychosocial complications. Recent studies show condoms reduce transmission, providing an important tool for counseling the patient with newly diagnosed genital herpes.|*Herpesvirus 2, Human/isolation & purification[MESH]|2-Aminopurine/*analogs & derivatives/therapeutic use[MESH]|Acyclovir/*analogs & derivatives/therapeutic use[MESH]|Antibodies, Viral/blood[MESH]|Antiviral Agents/therapeutic use[MESH]|Condoms[MESH]|Counseling[MESH]|Famciclovir[MESH]|Female[MESH]|Global Health[MESH]|HIV Infections/virology[MESH]|Herpes Genitalis/blood/epidemiology/*therapy/transmission[MESH]|Humans[MESH]|Male[MESH]|Patient Education as Topic[MESH]|Prevalence[MESH]|Seroepidemiologic Studies[MESH]|Valacyclovir[MESH]|Valine/*analogs & derivatives/therapeutic use[MESH]|Virus Activation[MESH] |
